A carregar...
Changes in Utilization of Generic Angiotensin Receptor Blockers Following Product Recalls in the United States
This pharmacoepidemiology study uses claims data to characterize angiotensin receptor blocker (ARB) prescription trends to evaluate whether recalls of ARBs prompted by discovery of potentially carcinogenic impurities shifted utilization of ARBs individually and as a drug class.
Na minha lista:
| Publicado no: | JAMA |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Medical Association
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6990815/ https://ncbi.nlm.nih.gov/pubmed/31910271 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jama.2019.17521 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|